Evidence map›Paper›PMID 31103411›Full record

ReviewTrends in biochemical sciences2019

Reactive Enamines and Imines In Vivo: Lessons from the RidA Paradigm.

Andrew J Borchert, Dustin C Ernst, Diana M Downs

Open access · greenAbstract readReview
In one paragraph

Review in Trends in biochemical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. DadY (PA5303) is required for fitness ofMicrobial cell (Graz, Austria) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Andrew J BorchertDepartment of Microbiology, University of Georgia, Athens, GA 30602, USA.
Dustin C ErnstCurrent address: Center for Circadian Biology, University of California, San Diego, San Diego, CA 92161, USA.
Diana M DownsDepartment of Microbiology, University of Georgia, Athens, GA 30602, USA. Electronic address: dmdowns@uga.edu.
University of Georgia · USCircadian (United States) · US

Funding

Rid family members neutralize endogenous metabolic stressorsR01GM095837 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI DOWNS, DIANA M. · 2011 to 2023
$3.7M
NIGMS NIH HHS R01 GM095837
6 · The paper itself

Abstract

Metabolic networks are webs of integrated reactions organized to maximize growth and replication while minimizing the detrimental impact that reactive metabolites can have on fitness. Enamines and imines, such as 2-aminoacrylate (2AA), are reactive metabolites produced as short-lived intermediates in a number of enzymatic processes. Left unchecked, the inherent reactivity of enamines and imines may perturb the metabolic network. Genetic and biochemical studies have outlined a role for the broadly conserved reactive intermediate deaminase (Rid) (YjgF/YER057c/UK114) protein family, in particular RidA, in catalyzing the hydrolysis of enamines and imines to their ketone product. Herein, we discuss new findings regarding the biological significance of enamine and imine production and outline the importance of RidA in controlling the accumulation of reactive metabolites.

Indexed as

AminesCatalysisHeat-Shock ProteinsHumansHydrolysisIminesKetonesMetabolic Networks and PathwaysRibonucleasesAminesHeat-Shock ProteinsIminesKetonesRibonucleasesRIDA protein, human2-aminoacrylate stressenamine/imine metabolismreactive metaboliteRidA

Identifiers

PMID31103411
PMCPMC6760865
OpenAlexW2946750368

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.